Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women
NCT03929419Completed
- Sponsor
- University Hospital Tübingen
- Start
- Apr 2019
- Primary completion
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of Generex Oral-lyn in diabetes mellitus (DM) (2 arms), sponsored by University Hospital Tübingen. Primary endpoint: Change in the peripheral insulin sensitivity. Started Apr 2019; status: completed.
02
Drugs
Generex Oral-lyn
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT03929419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03929419.